FDA finalizes pharmacology guidance for biosimilars

In final guidance issued Wednesday, FDA outlined pharmacology data requirements for proposed biosimilar products. In a Federal Register notice, the agency said the changes made to a draft version of the guidance are for clarity and are not substantive...